Moutih Rafei
Chief Tech/Sci/R&D Officer chez DEFENCE THERAPEUTICS INC.
Fortune : 87 500 $ au 31/03/2024
Profil
Moutih Rafei is the founder of Axiom Services, Inc., IntelliStem Technologies, Inc. He is currently working as the Chief Scientific Officer & Director at Defence Therapeutics Inc. Additionally, he holds the position of Professor & Principal Investigator at the University of Montréal.
Dr. Rafei obtained his doctorate degree from McGill University in 2009.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 02/11/2023 | 70 000 ( 0,16% ) | 87 500 $ | 31/03/2024 |
Postes actifs de Moutih Rafei
| Sociétés | Poste | Début |
|---|---|---|
| DEFENCE THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 09/10/2020 |
| University of Montréal | Corporate Officer/Principal | - |
Anciens postes connus de Moutih Rafei
| Sociétés | Poste | Fin |
|---|---|---|
IntelliStem Technologies, Inc.
 IntelliStem Technologies, Inc. BiotechnologyHealth Technology IntelliStem Technologies, Inc. is a Canadian biotechnology company that specializes in engineering stem cells for the development of next-generation cell therapy products. The private company is based in Toronto, Canada. The company's proprietary cell platforms, including Super Sentinel Cells (SSCs) for cancer therapeutics and IntelliCells for drug discovery and target identification, are genetically engineered. IntelliStem is currently moving into human clinical trials. The company was founded by Riam Shammaa, who has been the CEO since incorporation. | Founder | 01/08/2023 |
Formation de Moutih Rafei
| McGill University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| DEFENCE THERAPEUTICS INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
IntelliStem Technologies, Inc.
IntelliStem Technologies, Inc. BiotechnologyHealth Technology IntelliStem Technologies, Inc. is a Canadian biotechnology company that specializes in engineering stem cells for the development of next-generation cell therapy products. The private company is based in Toronto, Canada. The company's proprietary cell platforms, including Super Sentinel Cells (SSCs) for cancer therapeutics and IntelliCells for drug discovery and target identification, are genetically engineered. IntelliStem is currently moving into human clinical trials. The company was founded by Riam Shammaa, who has been the CEO since incorporation. | Health Technology |
